Advitech Signs PL Thomas for the U.S. Market

Advitech and PLT, a major U.S. distributor of active ingredients for nutraceutical, cosmeceutical and functional foods industries, have concluded a non-exclusive distribution agreement with a yearly commitment for Advitech's XP-828L ingredient.

29/10/08 Advitech Inc. has announced a distribution agreement with PL Thomas & Co., Inc. for the sale and marketing of its ingredient XP-828L for the United States market.

Advitech and PLT, a major U.S. distributor of active ingredients for nutraceutical, cosmeceutical and functional foods industries, have concluded a non-exclusive distribution agreement with a yearly commitment for Advitech's XP-828L ingredient, a patent-pending composition consisting of growth factors, especially TGF- B2, capable to maintain healthy cytokines levels and to support inflammatory process.

"The agreement with PLT is significant as it is an important player in several segments of the American market targeted by Advitech" stated Mr. Luc Clouâtre, Vice-President Business Development, Sales and Marketing at Advitech. Mr. Clouâtre further added, "PL Thomas has strong market visibility and existing business with many of the leading companies in the food and dietary supplements industry". PLT has an excellent understanding of the markets targeted by Advitech, and it will present the XP-828L to the U.S. market this week at the Supply Side West ("SSW") ingredients show. Product information will be displayed at the PLT booth, and Paul Flowerman, its President, will discuss this ingredient in his speech, an official part of the cosmeceutical track of the SSW educational program.

Other products of the Advitech portfolio, as well as several new innovations, could be added in the Advitech-PLT agreement upon further discussions.